Article
BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas
1 Jan 2000
Abstract excerpt
High BCAR1/p130Cas expression in primary breast tumour cytosol predicts a poor chance of response recurrent disease to tamoxifen treatment in patients with oestrogen receptor (ER)-positive breast carcinomas. In this study, we assessed whether BCAR1/p130Cas expression is altered during acquisition of anti-oestrogen resistance. BCAR1/p130Cas protein was quantitatively measured by chemiluminescent Western blot...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
